CD19 and B-cell chronic lymphocytic leukemia: Despite the fact that we performed microarray-based genomic profiling on whole peripheral blood samples, and not on (CD19) enriched cells, we have shown the feasibility of microarray-based profiling to detect genomic abnormalities in peripheral blood samples from CLL patients.